Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00241579 · ClinicalTrials.gov registry record · Phase 1

Analgesic Efficacy of Smoked Cannabis

A Phase 1 study of Pain and Hyperalgesia, sponsored by Center for Medicinal Cannabis Research.

Completed
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT00241579 is a Phase 1 study of Pain and Hyperalgesia that has completed, run by Center for Medicinal Cannabis Research. The registered enrollment target is 15 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00241579, a Phase 1 study of Pain and Hyperalgesia, has completed, sponsored by Center for Medicinal Cannabis Research.

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether or not inhaled marijuana displays any pain-relieving properties on experimentally-induced pain.

Conditions Studied

Interventions

  • DRUG Smoked Cannabis

Study Locations (1)

California

  • UC San Diego Medical Center - San Diego

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2002-02
Est. Completion 2004-01
Phase Phase 1

What the Registry Record Tells You About NCT00241579

The ClinicalTrials.gov registry entry for NCT00241579 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The listed sponsor is Center for Medicinal Cannabis Research, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Smoked Cannabis is the first listed.

NCT00241579 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00241579 about?

NCT00241579 is a clinical study titled "Analgesic Efficacy of Smoked Cannabis". The purpose of this study is to determine whether or not inhaled marijuana displays any pain-relieving properties on experimentally-induced pain.

What is the current status of trial NCT00241579?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2002-02. Estimated completion is 2004-01.

What conditions does trial NCT00241579 study?

This clinical trial studies the following conditions: Pain, Hyperalgesia.

What interventions are being tested in trial NCT00241579?

The interventions under investigation include: Smoked Cannabis (DRUG).

Who is sponsoring clinical trial NCT00241579?

This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00241579 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.